• imran.younus@hsa.edu.pk / doctorimran1@gmail.com
  • +92-3455892287
  • Ground Floor Block B / Health Services Academy, Prime Minister National Health Complex, Chak Shahzad, Islamabad

Dr. Mohammad Imran Younus

Associate Professor

Background

Dr. Imran has vast working experience and served in various capacities over spanning of twenty years in both public and private sector. Dr. Imran has experience in research, teaching MBBS, MPH and PhD students at international and national level medical universities and colleges. His all degrees including PhD registered with Pakistan Medical and Dental Council (PM&DC) and Higher Education Commission (HEC) of Pakistan. He is also a HEC approved Masters, MPhil and PhD supervisor in his respective field of Public Health. He is a co-author of the book, Public Health in China volume 2 “Endemic Disease in China”. Jointly published by People’s Medical Publishing House China and Springer Nature Singapore, 2019. His all research papers are published in the top reputed international journals with high impact factors.

Qualification:

  • PhD in Epidemiology and Health Statistics (Public Health), Xi’an Jiaotong University. P.R.China (2017)
  • M.P.H (Masters of Public Health), Sarhad University of Science and Information Technology (SUIT) Peshawar (Islamabad Campus)
  • MBBS (Bachelor of Medicine and Bachelor of Surgery), Xi’an Jiaotong University, School of Medicine, P.R.China

Degrees Accreditation and Recognition

  • All degrees including PhD registered with Pakistan Medical and Dental Council (PM&DC), Islamabad, Pakistan
  • All degrees including PhD are registered and equivalent by Higher Education Commission (HEC), Islamabad, Pakistan

Previous Work Experience

  • Assistant Professor, Rawalpindi Medical University, Pakistan
  • Lecturer, Xi’an Jiaotong University, China
  • Lecturer, Rawalpindi Medical University, Pakistan

Disciplines

  • Public Health
  • Epidemiology
  • Biostatistics
  • Infectious and chronic diseases
  • Environmental genetics

Research & Publications

  • Infectious disease prevention (TB, Dengue, STDs, COVID-19, Monkey pox )
  • Chronic disease prevention ( Cancer, CVD, Diabetes, Osteoarthritis etc)
  • Disability assessment
  • Quality of life
  • Digital health technologies, exploring how innovations like telehealth, wearable devices, and data analytics can enhance disease monitoring, healthcare delivery, and public health surveillance.
  • Emerging infectious diseases and pandemic preparedness Development of new and improved Epidemiologic Methods
  • Gene–environment interactions and their impact on human health